Stepping through the PORTAL: moving toward personalised management of oligorecurrent prostate cancer. Correa RJM, Bauman GS. Lancet Oncol 2026 Feb 16:S1470-2045(26)00003.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Correa RJM, Bauman GS. Stepping through the PORTAL: moving toward personalised management of oligorecurrent prostate cancer. Lancet Oncol 2026 Feb 16:S1470-2045(26)00003.
PMID: 41713472